4//SEC Filing
Coulie Bernard 4
Accession 0001746473-24-000113
CIK 0001746473other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:47 PM ET
Size
6.5 KB
Accession
0001746473-24-000113
Insider Transaction Report
Form 4
Coulie Bernard
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-07-09+75,625→ 521,646 total
Holdings
- 409,317(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]On July 28, 2022, the Reporting Person was granted 275,000 performance-vested stock units, the vesting of which were subject to the achievement of various pre-established performance criteria. On July 9, 2024, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the performance criteria tied to the company's total shareholder return relative to the Nasdaq Biotechnology Index, resulting in the vesting of 75,625 shares.
- [F2]Includes 1,489 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
- [F3]Shares held by The Coulie/Leyman Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
PLIANT THERAPEUTICS, INC.
CIK 0001746473
Entity typeother
Related Parties
1- filerCIK 0001808895
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:47 PM ET
- Size
- 6.5 KB